Medscape June 22, 2024
Kerry Dooley Young

ORLANDO, FL — Continuous glucose monitoring (CGM) of hospitalized patients with diabetes could provide early and important clues about changing insulin needs and reduce the need for many blood draws. However, more research is required to create the processes needed to make the most of this approach to care.

That was the message of researchers who presented their research on CGM testing here at the American Diabetes Association (ADA) 84th Scientific Sessions. Some of the most advanced research on CGM use in hospitalized patients has been conducted at Stanford Medicine, where CGM results have been integrated into electronic health records (EHRs).

CGM results appeared to fall within acceptable ranges for 99.3% of samples checked against finger-stick blood glucose (FSBG) testing,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health System / Hospital, Patient / Consumer, Provider, Survey / Study, Technology, Trends, Wearables
Apps and Wearables Bridge Gaps in Mental Health Care
Will the Apple Watch, Samsung Galaxy or Oura Rings Become “Intelligent Guardians” For Health?
Popular Wearables Can Help Doctors Manage Medication in Patients with Heart Disease
Apple secures win in EKG patent fight
Accurate and continuous remote monitoring of step length can be sensitive marker for neurological diseases and aging

Share This Article